Auron Therapeutics, Inc. · CIK 1746139
Auron Therapeutics, Inc.
Filings
2
Original notices
1
Amendments
1
Activity
Dec 23, 2025
through Aug 13, 2026
through Aug 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Dec 23, 2025 · D/A | Aug 13, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $42,289,180 | $12,000,000 | $-30,289,180 |
| Reported amount sold | $27,289,180 | $7,118,141 | $-20,171,039 |
| Reported investor count | — | 14 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001746139-25-000003 · Later SEC source: 0001746139-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $12,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $7,118,141
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001746139-26-000002D · Aug 13, 2026 · BiotechnologyOffering: $12,000,000Sold: $7,118,141
Compared with 0001746139-25-000003:
- Reported offering amount: $42,289,180 → $12,000,000
- Reported amount sold: $27,289,180 → $7,118,141
- Reported investor count: Unavailable → 14
-
0001746139-25-000003D/A · Dec 23, 2025 · BiotechnologyOffering: $42,289,180Sold: $27,289,180